Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Kornek

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Neuropediatrics|November 9, 2013
Treatment of pediatric multiple sclerosisBarbara Kornek
Patient Preference and Adherence|June 10, 2015
An update on the use of natalizumab in the treatment of multiple sclerosis: appropriate patient selection and special considerationsBarbara Kornek
Brain Research Bulletin|August 12, 2003
Neuropathology of multiple sclerosis-new conceptsBarbara Kornek, Hans Lassmann
Annals of Neurology|December 19, 2003
The expanding mutational spectrum of MERRF substitution G8361A in the mitochondrial tRNALys geneWalter Rossmanith, Thomas Raffelsberger, Julia Roka, et al.
Neuropediatrics|October 20, 2015
Age-Dependent Seroprevalence of JCV Antibody in ChildrenEva Maria Hennes, Barbara Kornek, Peter Huppke, et al.
Genes|August 29, 2020
Exome-Sequence Analyses of Four Multi-Incident Multiple Sclerosis FamiliesTobias Zrzavy, Fritz Leutmezer, Wolfgang Kristoferitsch, et al.
Neuropediatrics|March 27, 2019
Two Cases of Pediatric AQP4-Antibody Positive Neuromyelitis Optica Spectrum Disorder Successfully Treated with TocilizumabMarkus Breu, Sarah Glatter, Romana Höftberger, et al.
Frontiers in Neurology|July 17, 2020
Epidemiology of Pediatric NMOSD in Germany and AustriaChristian Lechner, Markus Breu, Eva-Maria Wendel, et al.
European Journal of Radiology|December 18, 2021
Imaging features to distinguish AQP4-positive NMOSD and MS at disease onset: A retrospective analysis in a single-center cohortTobias Zrzavy, Fritz Leutmezer, Paulus Rommer, et al.
Multiple Sclerosis and Related Disorders|May 31, 2022
Has the pandemic changed treatment strategy in multiple sclerosis?Gabriel Bsteh, Katharina Riedl, Nik Krajnc, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Neuropediatrics|November 9, 2013
Treatment of pediatric multiple sclerosisBarbara Kornek
Patient Preference and Adherence|June 10, 2015
An update on the use of natalizumab in the treatment of multiple sclerosis: appropriate patient selection and special considerationsBarbara Kornek
Brain Research Bulletin|August 12, 2003
Neuropathology of multiple sclerosis-new conceptsBarbara Kornek, Hans Lassmann
Annals of Neurology|December 19, 2003
The expanding mutational spectrum of MERRF substitution G8361A in the mitochondrial tRNALys geneWalter Rossmanith, Thomas Raffelsberger, Julia Roka, et al.
Neuropediatrics|October 20, 2015
Age-Dependent Seroprevalence of JCV Antibody in ChildrenEva Maria Hennes, Barbara Kornek, Peter Huppke, et al.
Genes|August 29, 2020
Exome-Sequence Analyses of Four Multi-Incident Multiple Sclerosis FamiliesTobias Zrzavy, Fritz Leutmezer, Wolfgang Kristoferitsch, et al.
Neuropediatrics|March 27, 2019
Two Cases of Pediatric AQP4-Antibody Positive Neuromyelitis Optica Spectrum Disorder Successfully Treated with TocilizumabMarkus Breu, Sarah Glatter, Romana Höftberger, et al.
Frontiers in Neurology|July 17, 2020
Epidemiology of Pediatric NMOSD in Germany and AustriaChristian Lechner, Markus Breu, Eva-Maria Wendel, et al.
European Journal of Radiology|December 18, 2021
Imaging features to distinguish AQP4-positive NMOSD and MS at disease onset: A retrospective analysis in a single-center cohortTobias Zrzavy, Fritz Leutmezer, Paulus Rommer, et al.
Multiple Sclerosis and Related Disorders|May 31, 2022
Has the pandemic changed treatment strategy in multiple sclerosis?Gabriel Bsteh, Katharina Riedl, Nik Krajnc, et al.
Pageof 7